State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee

Christine E. Ryan, Inhye E. Ahn, Aswin Sekar, Andrew Rawstron, Julia Almeida, Iñaki Martin-Subero, Erin M. Parry, Miguel Alcoceba, Dinis P. Calado, Alberto Orfao, Anton W. Langerak, Hendrik Veelken, Petra Langerbeins, Deborah M. Stephens, Sameer A. Parikh, Carsten U. Niemann, Sandrine Roulland, Kostas Stamatopoulos, Susan L. Slager, Tait Shanafelt, Paolo Ghia, Jessica Okosun, Matthew S. Davids

Open source

DOI
10.1038/s41408-025-01341-6
Published
2025-08-29
Container
Blood Cancer Journal
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41408-025-01341-6,
  title = {State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee},
  author = {Christine E. Ryan and Inhye E. Ahn and Aswin Sekar and Andrew Rawstron and Julia Almeida and Iñaki Martin-Subero and Erin M. Parry and Miguel Alcoceba and Dinis P. Calado and Alberto Orfao and Anton W. Langerak and Hendrik Veelken and Petra Langerbeins and Deborah M. Stephens and Sameer A. Parikh and Carsten U. Niemann and Sandrine Roulland and Kostas Stamatopoulos and Susan L. Slager and Tait Shanafelt and Paolo Ghia and Jessica Okosun and Matthew S. Davids},
  year = {2025},
  journal = {Blood Cancer Journal},
  doi = {10.1038/s41408-025-01341-6},
  url = {https://doi.org/10.1038/s41408-025-01341-6}
}

RIS

TY  - JOUR
TI  - State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee
AU  - Christine E. Ryan
AU  - Inhye E. Ahn
AU  - Aswin Sekar
AU  - Andrew Rawstron
AU  - Julia Almeida
AU  - Iñaki Martin-Subero
AU  - Erin M. Parry
AU  - Miguel Alcoceba
AU  - Dinis P. Calado
AU  - Alberto Orfao
AU  - Anton W. Langerak
AU  - Hendrik Veelken
AU  - Petra Langerbeins
AU  - Deborah M. Stephens
AU  - Sameer A. Parikh
AU  - Carsten U. Niemann
AU  - Sandrine Roulland
AU  - Kostas Stamatopoulos
AU  - Susan L. Slager
AU  - Tait Shanafelt
AU  - Paolo Ghia
AU  - Jessica Okosun
AU  - Matthew S. Davids
PY  - 2025
JO  - Blood Cancer Journal
DO  - 10.1038/s41408-025-01341-6
UR  - https://doi.org/10.1038/s41408-025-01341-6
ER  - 

APA

Ryan, C. E., Ahn, I. E., Sekar, A., Rawstron, A., Almeida, J., Martin-Subero, I., Parry, E. M., Alcoceba, M., Calado, D. P., Orfao, A., Langerak, A. W., Veelken, H., Langerbeins, P., Stephens, D. M., Parikh, S. A., Niemann, C. U., Roulland, S., Stamatopoulos, K., Slager, S. L., Shanafelt, T., Ghia, P., Okosun, J., & Davids, M. S. (2025). State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee. Blood Cancer Journal. https://doi.org/10.1038/s41408-025-01341-6

Source records